Evaluation of an antineoplastic agent. Dactinomycin (Cosmegen).
D002986:Clinical Trials as Topic; D003609:Dactinomycin / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D009396:Wilms Tumor / Q000188:drug therapy*
D003609:Dactinomycin